June 22, 2016
Eye drop manufacturer Altaire Pharmaceuticals Inc. can't evade accusations that its general counsel committed fraud with a letter knowingly overstating the company's chemical supply to eye care firm Paragon BioTeck Inc. during a manufacturing and distribution deal, a New York federal judge ruled Tuesday.